- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 24-06-2026: Press Release
24-06-2026 | 08:33 am
24-06-2026 | 08:33 am
Biocon's partner, Duopharma Biotech, secured Malaysian MoH insulin contracts worth over MYR 225 million. Biocon's Malaysian unit will supply human insulin, glargine, and aspart, reinforcing its commitment to diabetes care in the region.
No comments yet. Be the first to comment!